yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q28080999-0975FC0B-3BF5-4865-9324-1409C51B43CD
Q28080999-0975FC0B-3BF5-4865-9324-1409C51B43CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28080999-0975FC0B-3BF5-4865-9324-1409C51B43CD
Clinical use of proteasome inhibitors in the treatment of multiple myeloma
P2860
Q28080999-0975FC0B-3BF5-4865-9324-1409C51B43CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28080999-0975FC0B-3BF5-4865-9324-1409C51B43CD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6785018b40585742976f3b829f956883e220ebab
P2860
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.